Micregen Ltd

Micregen Ltd, based in Bolton, UK, is a small, active company founded nine years ago. With 17 employees and £280,593 in assets, it operates from a virtual address, a detail flagged by the fact 278 companies are registered at the same location. Six directors and two owners (though the list isn't exhaustive) manage the business. Micregen is an irregular importer, primarily dealing in glass and glassware, with just one month of import activity recorded back in August 2022.

The company's core business revolves around biotechnology research and experimental development, as evidenced by its website. It's developed an award-winning platform to manipulate stem cells, aiming to address underdevelopment and degenerative processes. The website details a novel approach in regenerative medicine, focusing on "Secretomix"—cell-free treatments harnessing stem cell paracrine factors. Micregen has created a GMP cell bank to supply stem cells, tackling historical challenges related to product variability. The company believes its innovative approach could change how critical and chronic diseases are managed.

Financially, Micregen Ltd presents a mixed picture. Current assets have dramatically fallen by 76%, dropping from £1.2 million to just £280,000. Debtor levels have also plummeted—a 94% decrease to a mere £33,000. Bank cash has shrunk by 63%, leaving just £250,000. While creditors have decreased slightly, the significant drops in assets and cash, coupled with a 20% increase in retained losses, suggest the company is burning through money. Net assets are down 20% to -£9.6 million. Despite these challenges, the company’s small size (meeting two of three conditions for being a small company) allows for agility. The lack of an auditor mentioned likely means the financial statements are unaudited.

Registered in England/Wales under the registration number 09714391, with a registered address at BL6 4SD, United Kingdom, Bolton, Fourth Floor, Unit 5b The Parklands.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.